Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-05-07
2011-11-22
Chung, Susannah (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S233500, C514S252180, C514S275000, C514S359000, C544S122000, C544S331000, C548S255000
Reexamination Certificate
active
08063035
ABSTRACT:
The present invention provides triazolyl aminopyrimidine compounds useful in the treatment of cancer.
REFERENCES:
patent: 2010/0130466 (2010-05-01), Brooks et al.
patent: WO89/07599 (1989-08-01), None
patent: WO2004063192 (2004-07-01), None
patent: WO2004089913 (2004-10-01), None
patent: WO 2006/066172 (2006-06-01), None
patent: WO2006066172 (2006-06-01), None
patent: WO2007092095 (2007-08-01), None
patent: WO2007117465 (2007-10-01), None
patent: WO2008076704 (2008-06-01), None
patent: WO2008144222 (2008-11-01), None
patent: WO2008144223 (2008-11-01), None
Patani et al., Chem. Rev., 1996, 96, pp. 3147-3176.
Crich Joyce Z.
Henry James Robert
Hu Hong
Jiang Delu
Li Hong-Yu
Chung Susannah
Eli Lilly and Company
Tucker Tina M.
LandOfFree
Triazolyl aminopyrimidine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazolyl aminopyrimidine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazolyl aminopyrimidine compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4266403